Atlas Trials

FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

Clinical trial NCT04625907 · RECRUITING

Trial details

NCT number
NCT04625907
Sponsor
University of Birmingham
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Rhabdomyosarcoma
Start date
2020-09-17
Primary completion
2030-06-01
Enrollment
1672

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.